11.9 C
Karachi
Friday, December 20, 2024
HomeTagsSanofi

Tag: Sanofi

Sanofi, GSK get Indian approval for trial of COVID-19 vaccine

Sanofi and GlaxoSmithKline have received an approval from Indian authorities for a late-stage clinical trial of their protein-based COVID-19 vaccine candidate, the drugmakers said...

Sanofi’s confidence in its COVID-19 vaccine candidates has increased this summer

The company is working on two of the more than 150 potential vaccines being developed across the world to tackle the COVID-19 pandemic

Britain nears US$625 million Sanofi/GSK COVID-19 vaccine deal: report

Britain is close to a 500 million pound ($624 million) supply deal with Sanofi and GlaxoSmithKline for 60 million doses of a potential COVID-19 vaccine.

Top pharma eyes approval of COVID-19 vaccine by first half of 2021

There are currently no vaccines to prevent the coronavirus that has infected more than 9 million people and killed over 469,000 globally

Pharma firm investigated over epilepsy drug linked to birth defects

Sanofi said on Tuesday it was being investigated over Depakine, an epilepsy drug which caused birth malfunctions

Drugmakers hike prices on over 200 drugs

Drugmakers including Pfizer, GlaxoSmithKline (GSK) and Sanofi are planning to hike U.S. list prices on more than 200 drugs in the United States on Wednesday

No carcinogen found in alternatives of Zantac: US FDA

The US Food and Drug Administration said on Wednesday that alternatives to popular heartburn drug Zantac and its generic versions

Philippines to charge drugmaker, govt over dengue deaths

The Philippine Department of Justice found probable cause to indict officials from a drugmaker and former and current Philippine health officials over a series of deaths related to a dengue vaccine

Our pills don’t cause racism, drugmaker Sanofi tells Roseanne

Pulled off air over a racist tweet, US sitcom star Roseanne Barr has blamed her outburst on a sleeping pill prompting a swift retort from pharma giant Sanofi.

Sanofi digs deep to buy US haemophilia group Bioverativ for $11.6 billion

PARIS: French healthcare group Sanofi has agreed to buy US haemophilia specialist Bioverativ for $11.6 billion, its biggest deal for seven years, which it...

Dengue vaccine not deadly, says maker

MANILA: A world-first dengue vaccination programme in the Philippines that was suspended over safety concerns will not cause anyone who was immunised to die,...

BREAKING NEWS

MUST READ